Investments Ideas and Research - Of Investor, By Investor, For Investor
Stocks, Mutual Funds, Bonds, Debentures, Fixed Deposit, Real Estate

November 16, 2007

EDELWEISS CAPITAL LIMITED – IPO Open

Edelweiss Capital (ECL) IPO is open now and doing great. First day itself, the issue got subscribed 6 times.

Incorporated in 1996, Edelweiss Capital Limited is in the business of providing investment banking, institutional equities, private client broking, asset management and investment advisory services, wealth management, insurance broking and wholesale financing services to corporate, institutional and high net worth individual clients. Edelweiss is headquartered in Nariman Point, Mumbai and operate from another 43 offices in 21 Indian cities and employed around 843 full time employees including 40 research professionals.

Objects of the Issue:

The objects of the Issue are to achieve the benefits of listing on the Stock Exchanges & to raise capital

  1. To enhance margin maintenance with stock exchanges;
  2. To establish additional offices and acquire office infrastructure;
  3. To enhance existing technological capacity and
  4. To prepayment of loans.


EDELWEISS CAPITAL LIMITED

Issue Period

November 15, 2007 to November 20, 2007

Market Lot

8 shares

Issue Size

8386147 Equity Shares

Minimum Order Quantity

8 shares

Issue Type

100% Book Building

Book Running Lead Manager

Citigroup Global Markets India Private Limited, Kotak Mahindra Capital Company Limited , and Lehman Brothers Securities Private Limited.

Face Value

Rs. 5/-

Syndicate Member

Kotak Securities Limited and Edelweiss Securities Limited

Price Range

Rs 725 TO Rs 825

Name of the registrar

Intime Spectrum Registry Limited

Tick Size

Re. 1/-

Address of the registrar

C-13, Pannalal Silk Mills Compound,L.B.S. Marg, Bhandup (West),Mumbai – 400 078.


 

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...
© Copyright 2009-12 InvestorSouk.com. Powered by Blogger.

© 2007-2012 Investor Souk: Our Research for your USE, All Rights Reserved.

Template by ScreenWritersArena